Overview
Availability
- Dr Mark Effron is:
- Available for supervision
Works
Search Professor Mark Effron’s works on UQ eSpace
2023
Journal Article
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE
Gupta, Kamal, Mehta, Harsh, Kim, Hwasoon, Stebbins, Amanda, Wruck, Lisa M., Muñoz, Daniel, Effron, Mark B., Anderson, R. David, Pepine, Carl J., Jain, Sandeep K., Girotra, Saket, DeWalt, Darren A., Whittle, Jeff, Benziger, Catherine P., Farrehi, Peter, Zhou, Li, Knowlton, Kirk U., Polonsky, Tamar S., Bradley, Steven M., Harrington, Robert A., Rothman, Russell L., Jones, W. Schuyler and Hernandez, Adrian F. (2023). Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE. American Heart Journal, 264, 31-39. doi: 10.1016/j.ahj.2023.06.001
2023
Journal Article
Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study
Chiarito, Mauro, Cao, Davide, Sartori, Samantha, Zhang, Zhongjie, Vogel, Birgit, Spirito, Alessandro, Smith, Kenneth F., Weintraub, William, Strauss, Craig, Toma, Catalin, DeFranco, Anthony, Effron, Mark B., Stefanini, Giulio, Keller, Stuart, Kapadia, Samir, Rao, Sunil V., Henry, Timothy D., Pocock, Stuart, Sharma, Samin, Dangas, George, Kini, Annapoorna, Baber, Usman and Mehran, Roxana (2023). Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study. European Heart Journal: Acute Cardiovascular Care, 12 (9), 594-603. doi: 10.1093/ehjacc/zuad083
2023
Journal Article
Novel tissue factor inhibition for thromboprophylaxis in COVID-19: primary results of the ASPEN-COVID-19 Trial
Hess, Connie N., Hsia, Judith, Carroll, Ian A., Nehler, Mark R., Ruf, Wolfram, Morrow, David A., Nicolau, Jose C., Berwanger, Otavio, Szarek, Michael, Capell, Warren H., Johri, Shilpa, Pursley, Michael S., Gupta, Ryan, Meehan, Patrick S., Franchi, Francesco, Effron, Mark B., Marshall, Debra, Graybill, Christopher A., Graybill, Sophie P., Keuer, Thomas, Bristow, Michael R. and Bonaca, Marc P. (2023). Novel tissue factor inhibition for thromboprophylaxis in COVID-19: primary results of the ASPEN-COVID-19 Trial. Arteriosclerosis, Thrombosis, and Vascular Biology, 43 (8), 1572-1582. doi: 10.1161/atvbaha.122.318748
2023
Journal Article
Internet versus noninternet participation in a decentralized clinical trial: lessons from the ADAPTABLE study
Shen, Rebecca, Mulder, Hillary, Wruck, Lisa, Weissler, E. Hope, Robertson, Holly R., Sharlow, Amber G., Kripalani, Sunil, Muñoz, Daniel, Effron, Mark B., Gupta, Kamal, Girotra, Saket, Whittle, Jeff, Benziger, Catherine P., VanWormer, Jeffrey J., Polonsky, Tamar S., Rothman, Russell L., Harrington, Robert A., Hernandez, Adrian F. and Jones, W. Schuyler (2023). Internet versus noninternet participation in a decentralized clinical trial: lessons from the ADAPTABLE study. Journal of the American Heart Association, 12 (13) e027899, 1-18. doi: 10.1161/jaha.122.027899
2023
Journal Article
Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): trial design and rationale
Joseph, Jacob, Pajewski, Nicholas M., Dolor, Rowena J., Sellers, Mary Ann, Perdue, Letitia H., Peeples, Sheronda R., Henrie, Adam M., Woolard, Nancy, Jones, W. Schuyler, Benziger, Catherine P., Orkaby, Ariela R., Mixon, Amanda S., VanWormer, Jeffrey J., Shapiro, Michael D., Kistler, Christine E., Polonsky, Tamar S., Chatterjee, Ranee, Chamberlain, Alanna M., Forman, Daniel E., Knowlton, Kirk U., Gill, Thomas M., Newby, L. Kristin, Hammill, Bradley G., Cicek, Mine S., Williams, Neely A., Decker, Jake E., Ou, Jiafu, Rubinstein, Jack, Choudhary, Gaurav ... Ramalingam, Ramesh (2023). Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): trial design and rationale. Journal of the American Geriatrics Society, 71 (6), 1701-1713. doi: 10.1111/jgs.18312
2022
Journal Article
Racial disparities and excess cardiovascular mortality before and during the COVID-19 pandemic: time for a solution
Obi, Koyenum and Effron, Mark B. (2022). Racial disparities and excess cardiovascular mortality before and during the COVID-19 pandemic: time for a solution. Mayo Clinic Proceedings, 97 (12), 2180-2183. doi: 10.1016/j.mayocp.2022.10.015
2022
Conference Publication
Contribution of Clinical Trial Event Data by Data Source: Insights From the ADAPTABLE Trial
Rymer, Jennifer A., Mulder, Hillary, Wruck, Lisa M., Munoz, Daniel, Kripalani, Sunil, Effron, Mark B., Gupta, Kamal, Handberg, Eileen M., Jain, Sandeep, Girotra, Saket, Whittle, Jeffrey, Hess, Rachel, Benziger, Catherine, Knowlton, Kirk U., Curtis, Lesley, Roe, Matthew T., Hammill, Bradley G., Rothman, Russell, Harrington, Josephine, Hernandez, Adrian F. and Jones, William (2022). Contribution of Clinical Trial Event Data by Data Source: Insights From the ADAPTABLE Trial. Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, Chicago Il, Nov 05-06, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2022
Conference Publication
Patient Differences in Prescription Patterns for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors When More Intensive Therapy is Needed
Effron, Mark B., Kakkar, Anjali, Desrosiers, Greg, Velasco-Gonzalez, Cruz and Cooper-dehoff, Rhonda M. (2022). Patient Differences in Prescription Patterns for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors When More Intensive Therapy is Needed. Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, Chicago Il, Nov 05-06, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2022
Conference Publication
Effect of Aspirin Dosing in Patients Treated With P2Y12 Inhibitors for Secondary Prevention of Cardiovascular Events
Girotra, Saket, Stebbins, Amanda, Wruck, Lisa M., Riley, Danielle, Kripalani, Sunil, Munoz, Daniel, Effron, Mark B., Gupta, Kamal, Whittle, Jeffrey, Benziger, Catherine, Zhou, Li, Farrehi, Peter M., Polonsky, Tamar S., Ahmad, Faraz S., Roe, Matthew T., Rothman, Russell, Harrington, Robert A., Hernandez, Adrian F. and Jones, William S. (2022). Effect of Aspirin Dosing in Patients Treated With P2Y12 Inhibitors for Secondary Prevention of Cardiovascular Events. Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, Chicago Il, Nov 05-06, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2022
Conference Publication
Comparison of Enteric Coated Aspirin With Plain Aspirin on Effectiveness and Safety in the ADAPTABLE Trial
Effron, Mark B., Sleem, Amber, Stebbins, Amanda, Wruck, Lisa M., Gravel, Guillaume, Munoz, Daniel, Re, Richard N., Gupta, Kamal, Pepine, Carl, Jain, Sandeep, Girotra, Saket, Whittle, Jeffrey, Benziger, Catherine, Farrehi, Peter M., Knowlton, Kirk U., Polonsky, Tamar S., Roe, Matthew T., Rothman, Russell T., Harrington, Robert A., Jones, William S. and Hernandez, Adrian F. (2022). Comparison of Enteric Coated Aspirin With Plain Aspirin on Effectiveness and Safety in the ADAPTABLE Trial. Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, Chicago Il, Nov 05-06, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2022
Journal Article
Proposal for a simple algorithmic approach to manage drug-drug interactions of oral anticoagulants with nirmatrelvir/ritonavir in COVID-19 outpatients
Rizk, John G., Lazo, Jose G., Gupta, Aashish, Lavie, Carl J. and Effron, Mark B. (2022). Proposal for a simple algorithmic approach to manage drug-drug interactions of oral anticoagulants with nirmatrelvir/ritonavir in COVID-19 outpatients. Seminars in Thrombosis and Hemostasis, 49 (01), 085-088. doi: 10.1055/s-0042-1750024
2022
Journal Article
Importance of More Potent Antiplatelet Therapy in Myocardial Infarction With Cardiac Arrest or Cardiogenic Shock
Effron, Mark B. (2022). Importance of More Potent Antiplatelet Therapy in Myocardial Infarction With Cardiac Arrest or Cardiogenic Shock. Mayo Clinic Proceedings, 97 (6), 1041-1043. doi: 10.1016/j.mayocp.2022.04.012
2022
Journal Article
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years
Rizk, John G., Gupta, Aashish, Lazo, Jose G., Sardar, Partha, Henry, Brandon Michael, Lavie, Carl J. and Effron, Mark B. (2022). To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years. Seminars in Thrombosis and Hemostasis, 49 (01), 062-072. doi: 10.1055/s-0042-1744302
2021
Journal Article
Therapeutic anticoagulation with heparin in critically ill patients with covid-19
Goligher, Ewan C., Bradbury, Charlotte A., McVerry, Bryan J., Lawler, Patrick R., Berger, Jeffrey S., Gong, Michelle N., Carrier, Marc, Reynolds, Harmony R., Kumar, Anand, Turgeon, Alexis F., Kornblith, Lucy Z., Kahn, Susan R., Marshall, John C., Kim, Keri S., Houston, Brett L., Derde, Lennie P.G., Cushman, Mary, Tritschler, Tobias, Angus, Derek C., Godoy, Lucas C., McQuilten, Zoe, Kirwan, Bridget-Anne, Farkouh, Michael E., Brooks, Maria M., Lewis, Roger J., Berry, Lindsay R., Lorenzi, Elizabeth, Gordon, Anthony C., Berry, Scott M. ... The REMAP-CAP, ACTIV-4a, and ATTACC Investigators (2021). Therapeutic anticoagulation with heparin in critically ill patients with covid-19. New England Journal of Medicine, 385 (9), 777-789. doi: 10.1056/NEJMoa2103417
2021
Journal Article
Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19
Lawler, Patrick R., Goligher, Ewan C., Berger, Jeffrey S., Neal, Matthew D., McVerry, Bryan J., Nicolau, Jose C., Gong, Michelle N., Carrier, Marc, Rosenson, Robert S., Reynolds, Harmony R., Turgeon, Alexis F., Escobedo, Jorge, Huang, David T., Bradbury, Charlotte A., Houston, Brett L., Kornblith, Lucy Z., Kumar, Anand, Kahn, Susan R., Cushman, Mary, McQuilten, Zoe, Slutsky, Arthur S., Kim, Keri S., Gordon, Anthony C., Kirwan, Bridget-Anne, Brooks, Maria M., Higgins, Alisa M., Lewis, Roger J., Lorenzi, Elizabeth, Berry, Scott M. ... The ATTACC, ACTIV-4a, and REMAP-CAP Investigators (2021). Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19. New England Journal of Medicine, 385 (9), 790-802. doi: 10.1056/NEJMoa2105911
2021
Journal Article
Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial
Kochar, Ajar, Summers, Mary B., Benziger, Catherine P., Marquis-Gravel, Guillaume, DeWalt, Darren A., Pepine, Carl J., Gupta, Kamal, Bradley, Steven M., Dodson, John A., Lampert, Brent C., Robertson, Holly, Polonsky, Tamar S., Jones, W. Schuyler and Effron, Mark B (2021). Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial. Clinical Trials, 18 (4) 1740774520988838, 449-456. doi: 10.1177/1740774520988838
2021
Journal Article
Comparative effectiveness of aspirin dosing in cardiovascular disease
Jones, W. Schuyler, Mulder, Hillary, Wruck, Lisa M., Pencina, Michael J., Kripalani, Sunil, Muñoz, Daniel, Crenshaw, David L., Effron, Mark B., Re, Richard N., Gupta, Kamal, David Anderson, R., Pepine, Carl J., Handberg, Eileen M., Manning, Brittney R., Jain, Sandeep K., Girotra, Saket, Riley, Danielle, DeWalt, Darren A., Whittle, Jeff, Goldberg, Ythan H., Roger, Veronique L., Hess, Rachel, Benziger, Catherine P., Farrehi, Peter, Zhou, Li, Ford, Daniel E., Haynes, Kevin, VanWormer, Jeffrey J., Knowlton, Kirk U. ... for the ADAPTABLE Team (2021). Comparative effectiveness of aspirin dosing in cardiovascular disease. New England Journal of Medicine, 384 (21), 1981-1990. doi: 10.1056/NEJMoa2102137
2020
Journal Article
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study
Chandrasekhar, Jaya, Baber, Usman, Sartori, Samantha, Aquino, Melissa, Moalem, Kamilia, Kini, Annapoorna S., Rao, Sunil V., Weintraub, William, Henry, Timothy D., Vogel, Birgit, Ge, Zhen, Muhlestein, Joseph B., Weiss, Sandra, Strauss, Craig, Toma, Catalin, DeFranco, Anthony, Claessen, Bimmer E., Keller, Stuart, Baker, Brian A., Effron, Mark B., Pocock, Stuart, Dangas, George, Kapadia, Samir and Mehran, Roxana (2020). Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study. Clinical Research in Cardiology, 109 (6), 725-734. doi: 10.1007/s00392-019-01561-4
2020
Journal Article
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry
Chandiramani, Rishi, Chen, Huazhen, Aoi, Shunsuke, Giustino, Gennaro, Claessen, Bimmer, Sartori, Samantha, Aquino, Melissa, Sorrentino, Sabato, Cao, Davide, Goel, Ridhima, Kini, Annapoorna, Rao, Sunil, Weintraub, William, Henry, Timothy D., Kapadia, Samir, DeFranco, Anthony, Muhlestein, Joseph B., Toma, Catalin, Effron, Mark B., Keller, Stuart, Baker, Brian A., Pocock, Stuart, Baber, Usman and Mehran, Roxana (2020). Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry. Catheterization and Cardiovascular Interventions, 95 (5) ccd.28369, 885-892. doi: 10.1002/ccd.28369
2020
Journal Article
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial
Marquis-Gravel, Guillaume, Roe, Matthew T., Robertson, Holly R., Harrington, Robert A., Pencina, Michael J., Berdan, Lisa G., Hammill, Bradley G., Faulkner, Madelaine, Muñoz, Daniel, Fonarow, Gregg C., Nallamothu, Brahmajee K., Fintel, Dan J., Ford, Daniel E., Zhou, Li, Daugherty, Sarah E., Nauman, Elizabeth, Kraschnewski, Jennifer, Ahmad, Faraz S., Benziger, Catherine P., Haynes, Kevin, Merritt, J. Greg, Metkus, Thomas, Kripalani, Sunil, Gupta, Kamal, Shah, Raj C., McClay, James C., Re, Richard N., Geary, Carol, Lampert, Brent C. ... Jones, W. Schuyler (2020). Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial. JAMA Cardiology, 5 (5) 0116, 598-607. doi: 10.1001/jamacardio.2020.0116
Supervision
Availability
- Dr Mark Effron is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
For media enquiries about Dr Mark Effron's areas of expertise, story ideas and help finding experts, contact our Media team: